{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:29Z","timestamp":1787313749947,"version":"build-2736575974"},"reference-count":237,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2020,7,28]]},"DOI":"10.3233\/jpd-201965","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T13:43:00Z","timestamp":1591105380000},"page":"791-818","source":"Crossref","is-referenced-by-count":61,"title":["Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk"],"prefix":"10.1177","volume":"10","author":[{"given":"Rakez","family":"Kayed","sequence":"first","affiliation":[{"name":"Departments of Neurology & Neuroscience & Cell Biology & Anatomy, University of Texas Medical Branch Galveston, Galveston, TX, USA"},{"name":"George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch Galveston, Galveston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Harvard Medical School, Boston, MA, USA"},{"name":"Ann Romney Center for Neurologic Diseases, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain E.","family":"Lesn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA"},{"name":"Institute of Translational Neuroscience, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-201965_ref1","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med"},{"key":"10.3233\/JPD-201965_ref2","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1002\/cne.23430","article-title":"Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases","volume":"521","author":"Arnold","year":"2013","journal-title":"J Comp Neurol"},{"key":"10.3233\/JPD-201965_ref3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JPD-201965_ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01247-7","article-title":"Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington\u2019s disease patients and transgenic mouse models","volume":"289","author":"Charles","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.3233\/JPD-201965_ref5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/hmg\/ddr507","article-title":"\u03b1-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington\u2019s disease","volume":"21","author":"Tom\u00e1s-Zapico","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-201965_ref6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201965_ref8","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JPD-201965_ref9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.23654","article-title":"Relation of neuropathology to cognition in persons without cognitive impairment","volume":"72","author":"Bennett","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201965_ref11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnagi.2013.00050","article-title":"Relation of neuropathology with cognitive decline among older persons without dementia","volume":"5","author":"Boyle","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JPD-201965_ref12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201965_ref13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"key":"10.3233\/JPD-201965_ref14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0197-4580(02)00123-9","article-title":"Emerging Alzheimer\u2019s disease therapies: focusing on the future","volume":"23","author":"Trojanowski","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-201965_ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Spires-Jones","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/10409238.2016.1226251","article-title":"Potential mechanisms and implications for the formation of tau oligomeric strains","volume":"51","author":"Gerson","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.3233\/JPD-201965_ref17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.febslet.2011.11.019","article-title":"\u03b1-Synuclein modifies huntingtin aggregation in living cells","volume":"586","author":"Herrera","year":"2012","journal-title":"FEBS Lett"},{"key":"10.3233\/JPD-201965_ref18","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/hmg\/ddu606","article-title":"\u03b1-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila","volume":"24","author":"Po\u00e7as","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-201965_ref19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-018-1886-z","article-title":"Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons","volume":"136","author":"Khan","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nm.3885","article-title":"Inhibition of amyloid-\u03b2 plaque formation by \u03b1-synuclein","volume":"21","author":"Bachhuber","year":"2015","journal-title":"Nat Med"},{"key":"10.3233\/JPD-201965_ref21","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"10.3233\/JPD-201965_ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-6598-4_9","article-title":"Tau oligomers as pathogenic seeds: preparation and propagation in vitro and in vivo","volume":"1523","author":"Gerson","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JPD-201965_ref23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.biopsych.2017.12.018","article-title":"\u03b1-Synuclein oligomers induce a unique toxic tau strain","volume":"84","author":"Castillo-Carranza","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JPD-201965_ref24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.3233\/JPD-201965_ref25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"\u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-201965_ref26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers\u2014neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front Neurosci"},{"key":"10.3233\/JPD-201965_ref27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-synuclein oligomers and fibrils: a spectrum of species, a of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JPD-150543","article-title":"Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases","volume":"5","author":"Melki","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-201965_ref29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble A\u03b2 oligomer production and toxicity","volume":"120 Suppl 1","author":"Larson","year":"2012","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref32","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1523\/JNEUROSCI.1899-16.2016","article-title":"Soluble conformers of A\u03b2 and tau alter selective proteins governing axonal transport","volume":"36","author":"Sherman","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref33","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","article-title":"The complex PrP(c)-Fyn couples human oligomeric A\u03b2 with pathological tau changes in Alzheimer\u2019s disease","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref34","doi-asserted-by":"crossref","first-page":"eaal2021","DOI":"10.1126\/scisignal.aal2021","article-title":"The amyloid-\u03b2 oligomer A\u03b2*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation","volume":"10","author":"Amar","year":"2017","journal-title":"Sci Signal"},{"key":"10.3233\/JPD-201965_ref35","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Stroh\u00e4ker","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JPD-201965_ref36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nn.4529","article-title":"\u03b1-Synuclein promotes dilation of the exocytotic fusion pore","volume":"20","author":"Logan","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.3233\/JPD-201965_ref40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0854.2008.00853.x","article-title":"Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling","volume":"10","author":"Ben Gedalya","year":"2009","journal-title":"Traffic"},{"key":"10.3233\/JPD-201965_ref41","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","article-title":"Synucleins regulate the kinetics of synaptic vesicle endocytosis","volume":"34","author":"Vargas","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","article-title":"Synucleins have multiple effects on presynaptic architecture","volume":"18","author":"Vargas","year":"2017","journal-title":"Cell Rep"},{"key":"10.3233\/JPD-201965_ref43","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","article-title":"\u03b1-synuclein multimers cluster synaptic vesicles and attenuate recycling","volume":"24","author":"Wang","year":"2014","journal-title":"Curr Biol"},{"key":"10.3233\/JPD-201965_ref44","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.3233\/JPD-201965_ref45","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bi4002369","article-title":"\u03b1-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers","volume":"52","author":"DeWitt","year":"2013","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref46","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1074\/jbc.M401076200","article-title":"Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study","volume":"279","author":"Nuscher","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","article-title":"Characterization of a novel protein regulated during the critical period for song learning in the zebra finch","volume":"15","author":"George","year":"1995","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-328X(91)90043-W","article-title":"The rat brain synucleins; family of proteins transiently associated with neuronal membrane","volume":"11","author":"Maroteaux","year":"1991","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JPD-201965_ref49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-3806(96)00210-6","article-title":"Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons","volume":"99","author":"Withers","year":"1997","journal-title":"Brain Res Dev Brain Res"},{"key":"10.3233\/JPD-201965_ref50","doi-asserted-by":"crossref","first-page":"42603","DOI":"10.1074\/jbc.M111.271130","article-title":"Membrane curvature sensing by amphipathic helices: a single liposome study using alpha-synuclein and annexin B12","volume":"286","author":"Jensen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref51","doi-asserted-by":"crossref","first-page":"e26255","DOI":"10.4161\/idp.26255","article-title":"Biophysical characterization of \u03b1-synuclein and its controversial structure","volume":"1","author":"Alderson","year":"2013","journal-title":"Intrinsically Disord Proteins"},{"key":"10.3233\/JPD-201965_ref52","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.febslet.2013.06.034","article-title":"Membrane bound \u03b1-synuclein is fully embedded in the lipid bilayer while segments with higher flexibility remain","volume":"587","author":"Wietek","year":"2013","journal-title":"FEBS Lett"},{"key":"10.3233\/JPD-201965_ref53","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","article-title":"Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation","volume":"279","author":"Tsigelny","year":"2012","journal-title":"FEBS J"},{"key":"10.3233\/JPD-201965_ref54","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bbamem.2016.03.012","article-title":"Membrane remodeling and mechanics: Experiments and simulations of \u03b1-Synuclein","volume":"1858","author":"West","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JPD-201965_ref55","doi-asserted-by":"crossref","first-page":"16838","DOI":"10.1073\/pnas.1307678110","article-title":"Hydration dynamics as an intrinsic ruler for refining protein structure at lipid membrane interfaces","volume":"110","author":"Cheng","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref56","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnmol.2016.00048","article-title":"Versatile structures of \u03b1-synuclein","volume":"9","author":"Wang","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JPD-201965_ref58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3389\/fnins.2018.00623","article-title":"Rationally designed variants of \u03b1-synuclein illuminate its in vivo structural properties in health and disease","volume":"12","author":"Dettmer","year":"2018","journal-title":"Front Neurosci"},{"key":"10.3233\/JPD-201965_ref59","doi-asserted-by":"crossref","first-page":"104543","DOI":"10.1016\/j.nbd.2019.104543","article-title":"Dynamic behaviors of \u03b1-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration","volume":"132","author":"Yeboah","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-201965_ref60","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/1873-3468.13047","article-title":"Refolding of helical soluble \u03b1-synuclein through transient interaction with lipid interfaces","volume":"592","author":"Rovere","year":"2018","journal-title":"FEBS Lett"},{"key":"10.3233\/JPD-201965_ref61","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref62","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","article-title":"Loss of native \u03b1-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells","volume":"26","author":"Dettmer","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-201965_ref63","doi-asserted-by":"crossref","first-page":"33928","DOI":"10.1038\/srep33928","article-title":"Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein","volume":"6","author":"Iljina","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref64","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1021\/ja310518p","article-title":"The dynamic structure of \u03b1-synuclein multimers","volume":"135","author":"Gurry","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JPD-201965_ref65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.1700465115","article-title":"GBA1 deficiency negatively affects physiological \u03b1-synuclein tetramers and related multimers","volume":"115","author":"Kim","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/bi501188a","article-title":"Purification of \u03b1-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity","volume":"54","author":"Luth","year":"2015","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref67","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref69","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A soluble \u03b1-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref70","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.1505953112","article-title":"KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity","volume":"112","author":"Dettmer","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref71","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation","volume":"6","author":"Dettmer","year":"2015","journal-title":"Nat Commun"},{"key":"10.3233\/JPD-201965_ref72","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1073\/pnas.1512077112","article-title":"From intrinsically disordered protein to context-dependent folding: The \u03b1-synuclein tetramer is teased out of hiding","volume":"112","author":"Pochapsky","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","article-title":"Abrogating native \u03b1-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease","volume":"100","author":"Nuber","year":"2018","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref74","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","article-title":"Monomeric synucleins generate membrane curvature","volume":"288","author":"Westphal","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref75","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1074\/jbc.M112.403311","article-title":"In vivo cross-linking reveals principally oligomeric forms of \u03b1-synuclein and \u03b2-synuclein in neurons and non-neural cells","volume":"288","author":"Dettmer","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pro.2056","article-title":"N-Terminal acetylation is critical for forming \u03b1-helical oligomer of \u03b1-synuclein","volume":"21","author":"Trexler","year":"2012","journal-title":"Protein Sci"},{"key":"10.3233\/JPD-201965_ref77","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"\u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref78","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature12125","article-title":"Properties of native brain \u03b1-synuclein","volume":"498","author":"Burr\u00e9","year":"2013","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref79","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1074\/jbc.C113.538249","article-title":"Evidence of native alpha-synuclein conformers in the human brain","volume":"289","author":"Gould","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref80","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","article-title":"Definition of a molecular pathway mediating \u03b1-synuclein neurotoxicity","volume":"35","author":"Burr\u00e9","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/jnc.13845","article-title":"Cross-linking for the analysis of \u03b1-synuclein in the enteric nervous system","volume":"139","author":"Corbill\u00e9","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref82","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1021\/acs.analchem.6b00419","article-title":"Characterization of \u03b1-synuclein multimer stoichiometry in complex biological samples by electrophoresis","volume":"88","author":"Killinger","year":"2016","journal-title":"Anal Chem"},{"key":"10.3233\/JPD-201965_ref83","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1042\/BST20120096","article-title":"Bacterial in-cell NMR of human \u03b1-synuclein: a disordered monomer by nature?","volume":"40","author":"Binolfi","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JPD-201965_ref84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric \u03b1-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature16871","article-title":"Parkinson\u2019s disease: Disorder in the court","volume":"530","author":"Alderson","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref86","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-9124-2_7","article-title":"Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers","volume":"1948","author":"Roberts","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JPD-201965_ref88","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain","volume":"138","author":"Roberts","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JPD-201965_ref89","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JPD-201965_ref90","doi-asserted-by":"crossref","first-page":"40263","DOI":"10.1038\/srep40263","article-title":"Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer\u2019s disease","volume":"7","author":"Majbour","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref91","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","article-title":"Elevated levels of alpha-synuclein oligomer in the cerebrospinal fluid of drug-naive patients with Parkinson\u2019s disease","volume":"7","author":"Park","year":"2011","journal-title":"J Clin Neurol"},{"key":"10.3233\/JPD-201965_ref92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J"},{"key":"10.3233\/JPD-201965_ref93","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","article-title":"Cerebrospinal fluid Tau\/alpha-synuclein ratio in Parkinson\u2019s disease and degenerative dementias","volume":"26","author":"Parnetti","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201965_ref94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JPD-201965_ref95","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1039\/c1ib00018g","article-title":"CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease","volume":"3","author":"Sierks","year":"2011","journal-title":"Integr Biol (Camb)"},{"key":"10.3233\/JPD-201965_ref96","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref97","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref98","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 \u2013>Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref99","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy {in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JPD-201965_ref101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201965_ref102","doi-asserted-by":"crossref","first-page":"35104","DOI":"10.1074\/jbc.M111.247965","article-title":"E46K human \u03b1-synuclein transgenic mice develop lewy-like and tau pathology associated with age-dependent, detrimental motor impairment","volume":"286","author":"Emmer","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref103","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","article-title":"Effects of serine 129 phosphorylation on \u03b1-synuclein aggregation, membrane association, and internalization","volume":"291","author":"Samuel","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2011.08.003","article-title":"Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson\u2019s disease and dementia with Lewy bodies","volume":"45","author":"Foulds","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-201965_ref105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","article-title":"Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation","volume":"137","author":"Sekiya","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref106","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am J Pathol"},{"key":"10.3233\/JPD-201965_ref107","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","article-title":"Soluble \u03b1-synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref108","doi-asserted-by":"crossref","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","article-title":"Selective lowering of synapsins induced by oligomeric \u03b1-synuclein exacerbates memory deficits","volume":"114","author":"Larson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-201965_ref111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-201965_ref112","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-018-0624-z","article-title":"The relevance of cerebrospinal fluid \u03b1-synuclein levels to sporadic and familial Alzheimer\u2019s disease","volume":"6","author":"Twohig","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JPD-201965_ref113","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-013-1148-z","article-title":"CSF \u03b1-synuclein improves diagnostic and prognostic performance of CSF tau and A\u03b2 in Alzheimer\u2019s disease","volume":"126","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref114","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.jalz.2013.10.004","article-title":"Increased CSF \u03b1-synuclein levels in Alzheimer\u2019s disease: correlation with tau levels","volume":"10","author":"Slaets","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JPD-201965_ref115","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.111","article-title":"\u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies","volume":"33","author":"van Steenoven","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-201965_ref116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-201965_ref117","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.3233\/JPD-201965_ref118","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3182a1aafe","article-title":"Impaired default network functional connectivity in autosomal dominant Alzheimer disease","volume":"81","author":"Chhatwal","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JPD-201965_ref119","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1523\/JNEUROSCI.3263-16.2017","article-title":"Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals","volume":"37","author":"Schultz","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2014.06.028","article-title":"Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits","volume":"36","author":"Ward","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-201965_ref121","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fncel.2017.00388","article-title":"\u03b1-Synuclein dimers impair vesicle fission during clathrin-mediated synaptic vesicle recycling","volume":"11","author":"Medeiros","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JPD-201965_ref122","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M000206200","article-title":"Dityrosine cross-linking promotes formation of stable \u03b1-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies","volume":"275","author":"Souza","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref123","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of \u03b1-synuclein filament assembly","volume":"45","author":"Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref124","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JPD-201965_ref125","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am J Pathol"},{"key":"10.3233\/JPD-201965_ref126","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.M109.069542","article-title":"Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref127","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1213151","article-title":"Atomic view of a toxic amyloid small oligomer","volume":"335","author":"Laganowsky","year":"2012","journal-title":"Science"},{"key":"10.3233\/JPD-201965_ref128","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","article-title":"Quaternary structure defines a large class of amyloid-\u03b2 oligomers neutralized by sequestration","volume":"11","author":"Liu","year":"2015","journal-title":"Cell Rep"},{"key":"10.3233\/JPD-201965_ref129","doi-asserted-by":"crossref","first-page":"163ra156","DOI":"10.1126\/scitranslmed.3004676","article-title":"\u03b1-Synuclein\u2013induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons","volume":"4","author":"Decressac","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.3233\/JPD-201965_ref130","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1523\/JNEUROSCI.1155-15.2015","article-title":"Nurr1 and retinoid X receptor ligands stimulate ret signaling in dopamine neurons and can alleviate \u03b1-synuclein disrupted gene expression","volume":"35","author":"Volakakis","year":"2015","journal-title":"J. Neurosci"},{"key":"10.3233\/JPD-201965_ref131","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J Mol Biol"},{"key":"10.3233\/JPD-201965_ref132","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson\u2019s disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref133","doi-asserted-by":"crossref","first-page":"E1994","DOI":"10.1073\/pnas.1421204112","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref134","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.M808591200","article-title":"Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer","volume":"284","author":"Kayed","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref135","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref136","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref137","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1016\/j.celrep.2019.10.089","article-title":"In vivo protein complementation demonstrates presynaptic \u03b1-synuclein oligomerization and age-dependent accumulation of 8-16-mer oligomer species","volume":"29","author":"Kiechle","year":"2019","journal-title":"Cell Rep"},{"key":"10.3233\/JPD-201965_ref138","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","article-title":"Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour","volume":"210","author":"George","year":"2008","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-201965_ref139","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref140","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref141","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref142","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J Clin Invest"},{"key":"10.3233\/JPD-201965_ref143","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of \u03b1-synuclein in Parkinson\u2019s disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res"},{"key":"10.3233\/JPD-201965_ref144","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid.eaay","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.3233\/JPD-201965_ref145","doi-asserted-by":"crossref","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.3233\/JPD-201965_ref146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0455-3","article-title":"Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain","volume":"5","author":"Delenclos","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JPD-201965_ref147","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u201cnew variant\u201d CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref148","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/0022-1317-73-2-329","article-title":"Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters","volume":"73","author":"Bessen","year":"1992","journal-title":"J Gen Virol"},{"key":"10.3233\/JPD-201965_ref149","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1128\/JVI.74.12.5542-5547.2000","article-title":"Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy","volume":"74","author":"Bartz","year":"2000","journal-title":"J Virol"},{"key":"10.3233\/JPD-201965_ref150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virusres.2014.10.002","article-title":"The diversity and relationship of prion protein self-replicating states","volume":"207","author":"Klimova","year":"2015","journal-title":"Virus Res"},{"key":"10.3233\/JPD-201965_ref151","doi-asserted-by":"crossref","first-page":"e1006323","DOI":"10.1371\/journal.ppat.1006323","article-title":"Prion strains in mammals: Different conformations leading to disease","volume":"13","author":"Morales","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.3233\/JPD-201965_ref152","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cell.2011.10.011","article-title":"The seeds of neurodegeneration: prion-like spreading in ALS","volume":"147","author":"Polymenidou","year":"2011","journal-title":"Cell"},{"key":"10.3233\/JPD-201965_ref153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson\u2019s disease: development and distribution of \u03b1-synuclein pathology","volume":"42","author":"Tredici","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-201965_ref154","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JPD-201965_ref155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JPD-201965_ref156","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of \u03b1-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref157","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0906759106","article-title":"Is Parkinson\u2019s disease a prion disorder?","volume":"106","author":"Olanow","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref158","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref159","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3233\/JPD-201965_ref160","doi-asserted-by":"crossref","first-page":"e0168700","DOI":"10.1371\/journal.pone.0168700","article-title":"Aggregated alpha-synuclein transfer efficiently between cultured human neuron-like cells and localize to lysosomes","volume":"11","author":"Domert","year":"2016","journal-title":"PloS One"},{"key":"10.3233\/JPD-201965_ref161","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41598-018-35811-8","article-title":"Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref162","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology","volume":"111","author":"Danzer","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref163","doi-asserted-by":"crossref","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","article-title":"Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading","volume":"113","author":"Iljina","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref164","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JPD-201965_ref165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","article-title":"Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice","volume":"126","author":"Rey","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s40478-019-0859-3","article-title":"\u03b1-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb","volume":"7","author":"Rey","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JPD-201965_ref167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref168","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.3233\/JPD-201965_ref169","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"key":"10.3233\/JPD-201965_ref170","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1212\/01.wnl.0000192103.24796.42","article-title":"Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis","volume":"66","author":"Glabe","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JPD-201965_ref171","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: Teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JPD-201965_ref172","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02251245","article-title":"Cognitive impairment in Parkinson\u2019s disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex","volume":"2","author":"Braak","year":"1990","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.3233\/JPD-201965_ref173","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.parkreldis.2014.06.018","article-title":"Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations","volume":"20","author":"Jacobson","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-201965_ref174","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref175","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease","volume":"31","author":"Mandal","year":"2006","journal-title":"Neurochem Res"},{"key":"10.3233\/JPD-201965_ref176","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2012.07847.x","article-title":"Cross-seeding effects of amyloid \u03b2-protein and \u03b1-synuclein","volume":"122","author":"Ono","year":"2012","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-201965_ref177","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","article-title":"Examining the mechanisms that link \u03b2-amyloid and \u03b1-synuclein pathologies","volume":"4","author":"Marsh","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JPD-201965_ref178","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1073\/pnas.1700239114","article-title":"Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates","volume":"114","author":"Chia","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref179","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-beta peptides trigger aggregation of alpha-synuclein in vitro","volume":"25","author":"K\u00f6ppen","year":"2020","journal-title":"Molecules"},{"key":"10.3233\/JPD-201965_ref180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-2-6","article-title":"Lack of alpha-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer\u2019s disease","volume":"2","author":"Kallhoff","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JPD-201965_ref182","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","article-title":"A brief overview of tauopathy: causes, consequences, and therapeutic strategies","volume":"38","author":"Orr","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JPD-201965_ref183","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JPD-201965_ref184","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neurobiolaging.2012.06.015","article-title":"MAPT H1 haplotype is associated with enhanced \u03b1-synuclein deposition in dementia with Lewy bodies","volume":"34","author":"Colom-Cadena","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-201965_ref185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2202-12-79","article-title":"Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson\u2019s disease","volume":"12","author":"Kaul","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.3233\/JPD-201965_ref186","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2004.07.016","article-title":"Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein","volume":"192","author":"Frasier","year":"2005","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-201965_ref187","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J"},{"key":"10.3233\/JPD-201965_ref188","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1096\/fj.06-6092com","article-title":"Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism","volume":"20","author":"Duka","year":"2006","journal-title":"FASEB J"},{"key":"10.3233\/JPD-201965_ref189","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an alpha-synuclein-overexpressing transgenic model of Parkinson\u2019s disease","volume":"33","author":"Haggerty","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-201965_ref190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-201965_ref191","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-201965_ref192","doi-asserted-by":"crossref","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"Neurodegeneration. Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"10.3233\/JPD-201965_ref193","doi-asserted-by":"crossref","first-page":"E1044","DOI":"10.3390\/v11111044","article-title":"Transmissibility versus pathogenicity of self-propagating protein aggregates","volume":"11","author":"Caughey","year":"2019","journal-title":"Viruses"},{"key":"10.3233\/JPD-201965_ref194","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaneurol.2013.1453","article-title":"Mechanisms of protein seeding in neurodegenerative diseases","volume":"70","author":"Walker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JPD-201965_ref195","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref196","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref197","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nan.12197","article-title":"Invited review: Prion-like transmission and spreading of tau pathology","volume":"41","author":"Clavaguera","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-201965_ref198","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"\u03b1-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356","volume":"274","author":"Jensen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref199","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(01)00689-X","article-title":"Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains","volume":"195","author":"Iseki","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.3233\/JPD-201965_ref200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res"},{"key":"10.3233\/JPD-201965_ref201","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.3233\/JPD-201965_ref202","doi-asserted-by":"crossref","first-page":"e17953","DOI":"10.1371\/journal.pone.0017953","article-title":"Tauopathic changes in the striatum of A53T \u03b1-synuclein mutant mouse model of Parkinson\u2019s disease","volume":"6","author":"Wills","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JPD-201965_ref203","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.3233\/JPD-201965_ref204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-018-0245-9","article-title":"Tau oligomers mediate \u03b1-synuclein toxicity and can be targeted by immunotherapy","volume":"13","author":"Gerson","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JPD-201965_ref205","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref207","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.arr.2019.100937","article-title":"Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism","volume":"56","author":"Chaudhuri","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JPD-201965_ref208","doi-asserted-by":"crossref","first-page":"e1003537","DOI":"10.1371\/journal.ppat.1003537","article-title":"Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases","volume":"9","author":"Morales","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.3233\/JPD-201965_ref209","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","article-title":"Preparation and characterization of neurotoxic tau oligomers","volume":"49","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-201965_ref210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JPD-201965_ref211","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-201965_ref212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/hmg\/ddr477","article-title":"\u03b1-Synuclein levels modulate Huntington\u2019s disease in mice","volume":"21","author":"Corrochano","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-201965_ref213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-018-0046-8","article-title":"Prospects for strain-specific immunotherapy in Alzheimer\u2019s disease and tauopathies","volume":"3","author":"Bittar","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.3233\/JPD-201965_ref214","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target alpha-synuclein pathology","volume":"298","author":"Brundin","year":"2017","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-201965_ref215","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.3390\/cells9020370","article-title":"Blood contamination in CSF and its impact on quantitative analysis of alpha-synuclein","volume":"9","author":"Barkovits","year":"2020","journal-title":"Cells"},{"key":"10.3233\/JPD-201965_ref216","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref217","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J Clin Invest"},{"key":"10.3233\/JPD-201965_ref218","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/acschemneuro.7b00325","article-title":"Resolving the atomistic modes of Anle138b inhibitory action on peptide oligomer formation","volume":"8","author":"Matthes","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JPD-201965_ref219","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15252\/emmm.201707825","article-title":"The diphenylpyrazole compound anle138b blocks A\u03b2 channels and rescues disease phenotypes in a mouse model for amyloid pathology","volume":"10","author":"Martinez Hernandez","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JPD-201965_ref220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13195-019-0522-z","article-title":"Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer\u2019s disease tau","volume":"11","author":"Brendel","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JPD-201965_ref221","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-015-1483-3","article-title":"Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies","volume":"130","author":"Wagner","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-201965_ref222","doi-asserted-by":"crossref","first-page":"16165","DOI":"10.1038\/s41598-018-34490-9","article-title":"The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease","volume":"8","author":"Price","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref223","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JPD-201965_ref224","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-201965_ref225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease","volume":"326","author":"Begum","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JPD-201965_ref226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737175.2015.1044981","article-title":"Clinical development of curcumin in neurodegenerative disease","volume":"15","author":"Hu","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JPD-201965_ref227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/cn3001203","article-title":"Curcumin modulates alpha-synuclein aggregation and toxicity","volume":"4","author":"Singh","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JPD-201965_ref228","doi-asserted-by":"crossref","first-page":"28511","DOI":"10.1038\/srep28511","article-title":"Effect of curcumin analogs on alpha-synuclein aggregation and cytotoxicity","volume":"6","author":"Jha","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-201965_ref229","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1073858412441372","article-title":"Molecular chaperones and co-chaperones in Parkinson disease","volume":"18","author":"Dimant","year":"2012","journal-title":"Neuroscientist"},{"key":"10.3233\/JPD-201965_ref230","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes \u03b1-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Lo Bianco","year":"2008","journal-title":"J Clin Invest"},{"key":"10.3233\/JPD-201965_ref231","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JPD-201965_ref232","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/ncomms6857","article-title":"Small molecule-mediated stabilization of vesicle-associated helical \u03b1-synuclein inhibits pathogenic misfolding and aggregation","volume":"5","author":"Fonseca-Ornelas","year":"2014","journal-title":"Nat Commun"},{"key":"10.3233\/JPD-201965_ref233","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","article-title":"Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form","volume":"106","author":"Collier","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-201965_ref234","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2018","journal-title":"Mol Cell"},{"key":"10.3233\/JPD-201965_ref235","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-201965_ref236","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","article-title":"Inhibiting stearoyl-CoA desaturase ameliorates \u03b1-synuclein cytotoxicity","volume":"25","author":"Vincent","year":"2018","journal-title":"Cell Rep"},{"key":"10.3233\/JPD-201965_ref237","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat Neurosci"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-201965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:48:11Z","timestamp":1777610891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-201965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":237,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-201965","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}